Clinical trials

  • N/A for Melanoma
  • TRANEXAMIC ACID for Hip fracture
  • PEMBROLIZUMAB for Cutaneous melanoma | Melanoma stage IIB | Melanoma stage IIC
  • FELZARTAMAB for IgA nephropathy
  • DRONABINOL, CANNABIDIOL for Advanced cancer
  • GSKVX000000044501 for Urinary tract infection
  • Metolazone for Congestive heart failure
  • ALXN1920 for Primary membranous nephropathy
  • DEFEROXAMINE MESILATE for Type 1 diabetes mellitus
  • REGN7508 for Venous thromboembolism (VTE)
  • Humanised IgG1 monoclonal antibody against human latent myostatin for Obesity | Overweight
  • budoprutug (TNT119) for Systemic lupus erythematosus